Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited
Published
Novo Nordisk just made a unique acquisition to help bolster the supply of Wegovy and Ozempic.
Full ArticlePublished
Novo Nordisk just made a unique acquisition to help bolster the supply of Wegovy and Ozempic.
Full ArticleThere's more for investors to get excited about in the biopharma world than just weight-loss drugs.